IDiyas

For the Inventor, By the Inventor

Nashville, TN, United States of America

James M Salovich

USPTO Granted Patents = 13


 

Average Co-Inventor Count = 7.6

ph-index = 8

Forward Citations = 110(Granted Patents)


Company Filing History:

goldMedal13 out of 1,153 
 
Vanderbilt University
 patents

Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 12144816 - Substituted indole Mcl-1 inhibitors (2024-11-19),
2. 11596639 - Substituted indole Mcl-1 inhibitors (2023-03-07),
3. 10807959 - WDR5-MLL1 inhibitors and modulators (2020-10-20),
4. 10501466 - WDR5 inhibitors and modulators (2019-12-10),
5. 10501421 - Substituted benzimidazoles as modulators of Ras signaling (2019-12-10),
6. 9868746 - Substituted 5-aminothieno[2,3-C]pyridazine-6-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4 (2018-01-16),
7. 9493481 - Substituted 5-aminothieno[2,3—C]pyridazine-6-carboxamide analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4 (2016-11-15),
8. 9192603 - Heterocyclic sulfone mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2015-11-24),
9. 9163015 - Pyrazolopyridine, pyrarolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2015-10-20),
10. 9108963 - Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2015-08-18),
11. 9056876 - Substituted 1H-pyrazolo[3',4′,4,5]thieno[2,3-b]pyridin-3-amine analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4 (2015-06-16),
12. 9056875 - Substituted pyrazolo[3',4′:4,5]thieno[2,3-C]pyridazin-3-amine analogs as positive allosteric modulators of the muscarinic acetylcholine receptor M4 (2015-06-16),
13. 8779157 - MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction (2014-07-15),

Title: Innovations of James M Salovich

Introduction

James M Salovich is a prominent inventor based in Nashville, TN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific proteins involved in cancer.

Latest Patents

Salovich holds a total of 13 patents, with his latest innovations focusing on substituted indole Mcl-1 inhibitors. These compounds are designed to inhibit the activity of the anti-apoptotic Bcl-2 family member Myeloid cell leukemia-1 (Mcl-1) protein. The disclosures provide pharmaceutical compositions and methods for using these compounds in the treatment of diseases characterized by the over-expression or dysregulation of the Mcl-1 protein, such as cancer.

Career Highlights

James M Salovich is affiliated with Vanderbilt University, where he conducts research and develops innovative solutions in the pharmaceutical field. His work has garnered attention for its potential impact on cancer treatment.

Collaborations

Salovich has collaborated with notable colleagues, including Craig William Lindsley and P Jeffrey Conn, enhancing the scope and depth of his research efforts.

Conclusion

James M Salovich's contributions to the field of pharmaceuticals, particularly through his patents on Mcl-1 inhibitors, highlight his role as an influential inventor in cancer research. His work continues to pave the way for advancements in treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…